Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

(2019) Nicholas J. Ashton et al.   Acta Neuropathologica Communications

Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study

(2018) Carlo Wilke et al.   JOURNAL OF NEUROLOGY

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

(2018) Lieke H.H. Meeter et al.   NEUROLOGY

Serum neurofilament light chain in progressive supranuclear palsy

(2018) Laura Donker Kaat et al.   PARKINSONISM & RELATED DISORDERS

Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

(2018) Ross W. Paterson et al.   Alzheimers Research & Therapy

The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias

(2018) Samir Abu-Rumeileh et al.   Alzheimers Research & Therapy

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

(2018) Piotr Lewczuk et al.   Alzheimers Research & Therapy

Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study

(2018) Samir Abu-Rumeileh et al.   JOURNAL OF ALZHEIMERS DISEASE

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

(2018) Yung-Shuan Lin et al.   Scientific Reports

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease

(2017) Simone Lista et al.   NEUROCHEMISTRY INTERNATIONAL

CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration

(2017) Daniel Alcolea et al.   NEUROLOGY

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Neurofilaments and Neurofilament Proteins in Health and Disease

(2017) Aidong Yuan et al.   Cold Spring Harbor Perspectives in Biology

Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival

(2017) Tobias Skillbäck et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

(2017) Niklas Mattsson et al.   JAMA Neurology

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis

(2017) Alessandra Gaiani et al.   JAMA Neurology

CSF Neurofilament Proteins Levels are Elevated in Sporadic Creutzfeldt-Jakob Disease

(2017) Jeroen J.J. van Eijk et al.   JOURNAL OF ALZHEIMERS DISEASE

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease

(2016) Sara Hall et al.   MOVEMENT DISORDERS

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

(2016) Jonathan D. Rohrer et al.   NEUROLOGY

Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration

(2016) Henrik Zetterberg   NEURON

Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net

(2016) Petra Steinacker et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

(2016) Henrik Zetterberg et al.   JAMA Neurology

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington’s Disease

(2016) Filipe Brogueira Rodrigues et al.   PLoS One

Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis

(2016) Zhouwei Xu et al.   PLoS One

Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease

(2016) Petra Steinacker et al.   Scientific Reports

Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis

(2015) Patrick Weydt et al.   ANNALS OF NEUROLOGY

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

(2015) N K Magdalinou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

(2015) David C. Bäckström et al.   JAMA Neurology

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

(2015) Megan K. Herbert et al.   Frontiers in Neurology

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

(2015) Xiang Wan et al.   BMC Medical Research Methodology

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

(2014) T. Skillback et al.   NEUROLOGY

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

(2013) Carole S. Scherling et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

(2013) Maria Landqvist Waldö et al.   BMC Neurology

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation study

(2008) Jan O Friedrich et al.   BMC Medical Research Methodology

Levels of brain related proteins in cerebrospinal fluid: An aid in the differential diagnosis of parkinsonian disorders

(2008) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS

Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease

(2008) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS